Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
ESSA Pharma Inc. (EPIX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| PFM Health Sciences, LP reports a 8.7% stake in ESSA Pharma Inc. |
| 02/14/2023 |
SC 13G/A
| Soleus Capital, LLC reports a 8.8% stake in ESSA Pharma Inc. |
| 02/14/2023 |
SC 13G/A
| Avidity Partners Management LP reports a 4.2% stake in ESSA Pharma Inc. |
| 02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 0% stake in Essa Pharma Inc. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/12/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 10% stake in ESSA Pharma Inc. |
| 02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.5% stake in ESSA Pharma Inc. |
| 02/14/2022 |
SC 13G/A
| RTW INVESTMENTS, LP reports a 6% stake in ESSA Pharma Inc. |
| 02/11/2022 |
SC 13G/A
| Vivo Capital IX, LLC reports a 1.4% stake in ESSA Pharma Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2022 |
SC 13G/A
| Soleus Capital, LLC reports a 8% stake in ESSA Pharma Inc. |
| 08/23/2021 |
SC 13G/A
| DRIEHAUS CAPITAL MANAGEMENT LLC reports a 0% stake in ESSA Pharma Inc |
| 08/17/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Vivo Capital IX, LLC reports a 4.7% stake in ESSA Pharma Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Omega Fund IV, L.P. reports a 2.3% stake in Essa Pharma Inc. |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/19/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/03/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Omega Fund IV, L.P. reports a 8.6% stake in Essa Pharma Inc. |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2020 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 9.7% stake in Essa Pharma Inc. |
| 06/27/2019 |
SC 13G/A
| BIOTECHNOLOGY VALUE FUND L P reports a 16.7% stake in ESSA Pharma Inc. |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/17/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/09/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|